A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours - PubMed (original) (raw)
. 2011 Oct 19;478(7369):399-403.
doi: 10.1038/nature10525.
Gregory Driessens, Steven Goossens, Khalil Kass Youssef, Anna Kuchnio, Amélie Caauwe, Panagiota A Sotiropoulou, Sonja Loges, Gaelle Lapouge, Aurélie Candi, Guilhem Mascre, Benjamin Drogat, Sophie Dekoninck, Jody J Haigh, Peter Carmeliet, Cédric Blanpain
Affiliations
- PMID: 22012397
- DOI: 10.1038/nature10525
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours
Benjamin Beck et al. Nature. 2011.
Abstract
Angiogenesis is critical during tumour initiation and malignant progression. Different strategies aimed at blocking vascular endothelial growth factor (VEGF) and its receptors have been developed to inhibit angiogenesis in cancer patients. It has become increasingly clear that in addition to its effect on angiogenesis, other mechanisms including a direct effect of VEGF on tumour cells may account for the efficiency of VEGF-blockade therapies. Cancer stem cells (CSCs) have been described in various cancers including squamous tumours of the skin. Here we use a mouse model of skin tumours to investigate the impact of the vascular niche and VEGF signalling on controlling the stemness (the ability to self renew and differentiate) of squamous skin tumours during the early stages of tumour progression. We show that CSCs of skin papillomas are localized in a perivascular niche, in the immediate vicinity of endothelial cells. Furthermore, blocking VEGFR2 caused tumour regression not only by decreasing the microvascular density, but also by reducing CSC pool size and impairing CSC renewal properties. Conditional deletion of Vegfa in tumour epithelial cells caused tumours to regress, whereas VEGF overexpression by tumour epithelial cells accelerated tumour growth. In addition to its well-known effect on angiogenesis, VEGF affected skin tumour growth by promoting cancer stemness and symmetric CSC division, leading to CSC expansion. Moreover, deletion of neuropilin-1 (Nrp1), a VEGF co-receptor expressed in cutaneous CSCs, blocked VEGF's ability to promote cancer stemness and renewal. Our results identify a dual role for tumour-cell-derived VEGF in promoting cancer stemness: by stimulating angiogenesis in a paracrine manner, VEGF creates a perivascular niche for CSCs, and by directly affecting CSCs through Nrp1 in an autocrine loop, VEGF stimulates cancer stemness and renewal. Finally, deletion of Nrp1 in normal epidermis prevents skin tumour initiation. These results may have important implications for the prevention and treatment of skin cancers.
Comment in
- Tumour biology: Skin-cancer stem cells outwitted.
Benitah SA. Benitah SA. Nature. 2011 Oct 19;478(7369):329-30. doi: 10.1038/478329a. Nature. 2011. PMID: 22012386 No abstract available. - Cancer stem cells. VEGF promotes stemness.
Seton-Rogers S. Seton-Rogers S. Nat Rev Cancer. 2011 Nov 17;11(12):831. doi: 10.1038/nrc3176. Nat Rev Cancer. 2011. PMID: 22089417 No abstract available.
Similar articles
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E, Brohée S, Salmon I, Dubois C, del Marmol V, Fuks F, Beck B, Blanpain C. Boumahdi S, et al. Nature. 2014 Jul 10;511(7508):246-50. doi: 10.1038/nature13305. Epub 2014 Jun 8. Nature. 2014. PMID: 24909994 - SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma.
Siegle JM, Basin A, Sastre-Perona A, Yonekubo Y, Brown J, Sennett R, Rendl M, Tsirigos A, Carucci JA, Schober M. Siegle JM, et al. Nat Commun. 2014 Jul 31;5:4511. doi: 10.1038/ncomms5511. Nat Commun. 2014. PMID: 25077433 Free PMC article. - Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas.
Shahrabi-Farahani S, Wang L, Zwaans BM, Santana JM, Shimizu A, Takashima S, Kreuter M, Coultas L, D'Amore PA, Arbeit JM, Akslen LA, Bielenberg DR. Shahrabi-Farahani S, et al. Lab Invest. 2014 Jul;94(7):752-65. doi: 10.1038/labinvest.2014.66. Epub 2014 May 5. Lab Invest. 2014. PMID: 24791743 Free PMC article. - Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D. Nassehi D. Dan Med J. 2013 Apr;60(4):B4626. Dan Med J. 2013. PMID: 23651727 Review. - New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.
Zhao L, Chen H, Lu L, Wang L, Zhang X, Guo X. Zhao L, et al. J Drug Target. 2021 Feb;29(2):155-167. doi: 10.1080/1061186X.2020.1815210. Epub 2020 Sep 3. J Drug Target. 2021. PMID: 32838575 Review.
Cited by
- Polarity and stratification of the epidermis.
Muroyama A, Lechler T. Muroyama A, et al. Semin Cell Dev Biol. 2012 Oct;23(8):890-6. doi: 10.1016/j.semcdb.2012.08.008. Epub 2012 Aug 31. Semin Cell Dev Biol. 2012. PMID: 22960184 Free PMC article. Review. - Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
Calvani M, Bianchini F, Taddei ML, Becatti M, Giannoni E, Chiarugi P, Calorini L. Calvani M, et al. Oncotarget. 2016 Aug 9;7(32):51138-51149. doi: 10.18632/oncotarget.9939. Oncotarget. 2016. PMID: 27303923 Free PMC article. - Apoptosis and tissue thinning contribute to symmetric cell division in the developing mouse epidermis in a nonautonomous way.
Soffer A, Mahly A, Padmanabhan K, Cohen J, Adir O, Loushi E, Fuchs Y, Williams SE, Luxenburg C. Soffer A, et al. PLoS Biol. 2022 Aug 15;20(8):e3001756. doi: 10.1371/journal.pbio.3001756. eCollection 2022 Aug. PLoS Biol. 2022. PMID: 35969606 Free PMC article. - Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z, Qin J, Wang D, Geng S. Fan Z, et al. J Cell Mol Med. 2019 May;23(5):3097-3107. doi: 10.1111/jcmm.13959. Epub 2019 Mar 1. J Cell Mol Med. 2019. PMID: 30825266 Free PMC article. - SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E, Brohée S, Salmon I, Dubois C, del Marmol V, Fuks F, Beck B, Blanpain C. Boumahdi S, et al. Nature. 2014 Jul 10;511(7508):246-50. doi: 10.1038/nature13305. Epub 2014 Jun 8. Nature. 2014. PMID: 24909994
References
- Development. 1999 Mar;126(6):1149-59 - PubMed
- Cancer Cell. 2007 Jan;11(1):53-67 - PubMed
- Nature. 2011 Feb 17;470(7334):353-8 - PubMed
- Cancer Cell. 2007 Jan;11(1):69-82 - PubMed
- Cancer Res. 2004 May 15;64(10):3508-16 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous